GLORIA

GEOMAR Library Ocean Research Information Access

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    Online Resource
    Online Resource
    Universidad Tecnica de Manabi ; 2022
    In:  International journal of health sciences ( 2022-04-08), p. 3117-3127
    In: International journal of health sciences, Universidad Tecnica de Manabi, ( 2022-04-08), p. 3117-3127
    Abstract: Objectives: Several unique characteristics have been found in severe COVID19, such as lymphopenia, old age, high CRP level, elevated D dimer levels and underlying comorbid diseases. Serum albumin, being a negative acute phase reactant has been found to be associated with inflammatory response and poor outcomes in infectious diseases. The aim of the study was to analyse whether the serum albumin levels on admission might reflect the severity of systemic inflammation in COVID 19 infection and thus serve as an early predictive factor for COVID 19 outcomes. Materials and Method: This retrospective observational study included 185 COVID-19 positive patients. Laboratory data was recorded from blood samples collected at admission and analyzed by standard methods in the laboratory. Hypoalbuminemia was defined as serum albumin levels 〈 3.5g/dl. p 〈 0.05 was considered statistically significant. Results: In the 185 COVID 19 patients studied, average age was 51.29 (±15.68) years. The study population had a male predominance (68.11%). 85 (45.95%) individuals were found to have hypoalbuminemia on admission. 18 (9.73%) deaths were reported amongst the study population and  a significant association was found between low serum albumin levels on admission and mortality.(p 〈 0.001).
    Type of Medium: Online Resource
    ISSN: 2550-696X , 2550-6978
    URL: Issue
    Language: Unknown
    Publisher: Universidad Tecnica de Manabi
    Publication Date: 2022
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 2
    In: Diseases of the Colon & Rectum, Ovid Technologies (Wolters Kluwer Health), Vol. 66, No. 6 ( 2023-06), p. 840-847
    Abstract: Up to 10% of patients develop new, persistent opioid use after surgery. We aimed to assess our prescribing practices and patient utilization of opioids after colorectal surgery. OBJECTIVE: This study aimed to implement an opioid-prescribing protocol that will minimize the number of postoperative opioids to decrease community circulation and persistent use by patients. DESIGN: This was a single-institution, prospective study based on questionnaires of postoperative patients in 2019 and 2020 to determine opioid prescribing and usage patterns. Based on these preliminary results, a protocol was implemented in which patients were discharged with 5 or 15 oxycodone 5 mg equivalents based on opioid usage in the 24 hours before discharge. Patients were surveyed after protocol implementation. SETTINGS: Our institution is a large referral center for surgical treatment of colorectal disease. PATIENTS: Adults who underwent inpatient abdominal colorectal procedures. MAIN OUTCOME MEASURES: End points included the number of opioids prescribed, number of prescribed opioids taken, and refill rate. Nonparametric testing was used. RESULTS: Of 77 eligible patients, 61 were opioid naive. Preprotocol, opioid-naive patients (n = 29) were prescribed a median of 30 (interquartile range [IQR], 30–45) tablets but took only 10 (IQR, 0–10; p 〈 0.0001). Eighty-three percent took 20 or fewer tablets. After protocol implementation, opioid-naive patients (n = 32) were prescribed fewer tablets (median 15; IQR, 7–15; p 〈 0.0001) but took a similar number of tablets as the preprotocol group (median 10; IQR, 0–10; p = 0.21). The refill rate remained similar (13.8% vs 18.8%; p = 0.60). Protocol adherence was 90.6%. LIMITATIONS: This study is limited by sample size, cohort heterogeneity, and generalizability. CONCLUSIONS: Patients took significantly fewer opioids than were prescribed. Our protocol limited overprescribing and resulted in fewer opioids in the community without opportunity costs such as increased refills. Long-term studies are needed to assess the effects of persistent opioid use after surgery. See Video Abstract at http://links.lww.com/DCR/C93. EL PROTOCOLO DE PRESCRIPCIÓN DE ALTA REDUCE LOS OPIOIDES EN CIRCULACIÓN Y NO AUMENTA LOS REABASTECIMIENTOS DESPUÉS DE LA CIRUGÍA COLORECTAL ANTECEDENTES: Hasta el 10% de los pacientes desarrollan un nuevo uso persistente de opioides después de la cirugía. Nuestro objetivo fue evaluar nuestras prácticas de prescripción y la utilización de opioides por parte de los pacientes después de la cirugía colorrectal. OBJETIVO: Nuestro objetivo es implementar un protocolo de prescripción de opioides que minimice la cantidad de opioides posoperatorios para disminuir la circulación en la comunidad y el uso persistente por parte de los pacientes. DISEÑO: Estudio prospectivo, de una sola institución, basado en cuestionarios de pacientes postoperatorios en 2019 y 2020 para determinar los patrones de prescripción y uso de opioides. Con base en estos resultados preliminares, se implementó un protocolo en el que los pacientes eran dados de alta con 5 o 15 equivalentes de oxicodona de 5 mg según el uso de opioides en las 24 horas previas al alta. Los pacientes fueron encuestados después de la implementación del protocolo. AJUSTES: Nuestra institución es un gran centro de referencia para el tratamiento quirúrgico de la enfermedad colorrectal. PACIENTES: Adultos que se sometieron a procedimientos colorrectales abdominales con hospitalización. PRINCIPALES MEDIDAS DE RESULTADO: Los criterios de valoración incluyeron el número de opioides recetados, el número de opioides recetados tomados y la tasa de reabastecimiento. Se utilizaron pruebas no paramétricas. RESULTADOS: De 77 pacientes elegibles, 61 no habian recibido opioides. A los pacientes sin tratamiento previo con opioides antes del protocolo (n = 29) se les prescribió una mediana de 30 (rango intercuartilico [RIC] 30–45) comprimidos, pero solo tomaron 10 (RIC 0.10, p 〈 0,0001). El ochenta y tres por ciento tomo ≤20 comprimidos. Despues de la implementacion del protocolo, a los pacientes sin tratamiento previo con opioides (n = 32) se les prescribieron menos comprimidos (15; RIC 7.15, p 〈 0,0001), pero tomaron un numero similar antes de la intervención (10; RIC 0–10, p = 0,21). La tasa de reabastecimiento se mantuvo similar (13,8% frente a 18,8%, p = 0,60). La adherencia al protocolo fue del 90,6%. LIMITACIONES: Este estudio está limitado por el tamaño de la muestra, la heterogeneidad de la cohorte y la generalización. CONCLUSIONES: Los pacientes tomaron significativamente menos opioides de los prescritos. Nuestro protocolo limitó la prescripción excesiva y dio como resultados menos opioides en la comunidad sin costos de oportunidad, como el aumento de reabastecimiento. Se necesitan estudios a largo plazo para evaluar los efectos sobre el uso persistente de opioides después de la cirugía. Consulte Video Resumen en http://links.lww.com/DCR/C93. (Traducción—Dr. Francisco M. Abarca-Rendon)
    Type of Medium: Online Resource
    ISSN: 0012-3706
    Language: English
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date: 2023
    detail.hit.zdb_id: 2046914-7
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 3
    Online Resource
    Online Resource
    Akshantala Enterprises Private Limited ; 2021
    In:  Journal of Evolution of Medical and Dental Sciences Vol. 10, No. 45 ( 2021-12-28), p. 3931-3935
    In: Journal of Evolution of Medical and Dental Sciences, Akshantala Enterprises Private Limited, Vol. 10, No. 45 ( 2021-12-28), p. 3931-3935
    Abstract: BACKGROUND Hyperglycemia is a common finding during the admission of non-diabetic patients with acute coronary syndrome. It is very essential to differentiate this stress hyperglycemia from the hyperglycemia in latent diabetics whose diabetes may have been unmasked by the stress of acute coronary syndrome (ACS). We conducted this study to evaluate stress hyperglycemia in non-diabetic patients with ACS. METHODS We conducted this cross sectional study in the Department of Medicine, KIMS Hospital, Karad, over a period of one year. Non-diabetic patients with HbA1c 〈 6.5 admitted in our hospital with ACS were included in the study. We included a total of 100 patients in our study, their detailed history, clinical examination and lab evaluation was done. We divided the patients into two groups, Group A were normoglycaemic patients and Group B were acute phase hyperglycemic patients with blood sugars more than 160. Correlation between the blood sugar levels and outcome of the patients was done. RESULTS Mean age was 65.23 ± 21.05 years. No significant difference in risk factor distribution in the two groups was seen. (p 〉 0.05) We had 47 cases of unstable angina (UA – 47%) followed by 43 cases of STEMI (43 %) and 10 cases of NSTEMI (10 %). We observed a significant difference in the presence of complications in the two groups (p 〈 0.001), Group B patients with hyperglycemia had more complications. Significant difference was seen between the presence of heart failure, arrhythmias and shock in the two groups, with group B having more incidences of these (p 〈 0.05). Significant difference in the outcome of the two groups was seen (p = 0.012). We observed that out of 38 patients in Group B with hyperglycemia, there were 8 deaths (21.05%) as compared to 3 deaths (4.84%) in Group A patients. CONCLUSIONS We observed that the high prevalence (38%) of stress in non-diabetic ACS patients is responsible for significantly more complications, more chances of heart failure, arrhythmia, shock and more deaths. KEY WORDS Acute Coronary Syndrome, Stress Hyperglycemia, Non-Diabetic Patients, Outcome
    Type of Medium: Online Resource
    ISSN: 2278-4748 , 2278-4802
    Uniform Title: English
    Language: Unknown
    Publisher: Akshantala Enterprises Private Limited
    Publication Date: 2021
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 4
    Online Resource
    Online Resource
    Akshantala Enterprises Private Limited ; 2021
    In:  Journal of Evolution of Medical and Dental Sciences Vol. 10, No. 45 ( 2021-12-23), p. 3880-3883
    In: Journal of Evolution of Medical and Dental Sciences, Akshantala Enterprises Private Limited, Vol. 10, No. 45 ( 2021-12-23), p. 3880-3883
    Abstract: BACKGROUND The world is still experiencing corona virus disease-19 (COVID-19) pandemic. So far, we experienced a total of more than 23 crore cases and 47 lakh deaths from COVID 19 disease. Severe acute respiratory syndrome – corona virus – 2 (SARSCoV-2) was believed to affect lipid metabolism, with many authors reporting an increase in triglycerides and a decrease in high density lipoprotein (HDL) levels. This study gave the clinical features of COVID-19 patients with various HDL-C levels and an interrelation between HDL-C levels and the risk for adverse outcome in the form of deaths. METHODS We conducted a cross sectional study on 100 COVID-19 adult patients diagnosed by reverse transcription – polymerase chain reaction (RT-PCR) test admitted to the medicine department, from January 2020 to December 2020, who were also tested for lipid parameters. The detailed history and lab parameters of the patients were collected and the severe outcome of the same was measured in terms of deaths. RESULTS The mean age of study participants was 57.92 ± 12.41 years. Majority of the participants were from the age group of 41 to 60 years with 50 patients (50 %). There were 73 males (73 %) and 27 females (27 %) in our study. We observed that a total of 36 patients had co-morbidities (36 %), such as diabetes seen in 22 cases (22 %), hypertension in 18 cases (18 %), ischaemic heart disease (IHD) in 8 cases (8 %). A significant association was seen between the presence of co-morbidities and deaths in our study (P = 0.043). A significant association was seen between the patients who required intensive care and deaths (P 〈 0.001). We found a significant difference between the triglycerides and HDL parameters of lipid profiles in patients who died as compared to those who survived. (P 〈 0.05) The mean triglyceride level in patients who died was 223.14 ± 56.59, significantly higher than those who survived 134.43 ± 96.16. (P = 0.003) CONCLUSIONS The lipid profile evaluation in our study was found to be effective in detecting the correlation of severity and outcome in COVID-19 patients. We conclude that the severity of COVID-19 cases is associated with low HDL and high triglyceride levels. KEY WORDS COVID-19, Lipid Profile, HDL, Triglycerides, Patient Outcome.
    Type of Medium: Online Resource
    ISSN: 2278-4748 , 2278-4802
    Uniform Title: English
    Language: Unknown
    Publisher: Akshantala Enterprises Private Limited
    Publication Date: 2021
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 5
    In: Annals of Surgery, Ovid Technologies (Wolters Kluwer Health), Vol. 275, No. 2 ( 2022-02), p. e428-e432
    Abstract: Investigate the association between neoadjuvant treatment strategy and perioperative complications in patients undergoing proctectomy for nonmetastatic rectal cancer. Summary of Background Data: Neoadjuvant SC-TNT is an alternative to neoadjuvant CRT for rectal cancer. Some have argued that short-course radiation and extended radiation-to-surgery intervals increase operative difficulty and complication risk. However, the association between SC-TNT and surgical complications has not been previously investigated. Methods: This single-center retrospective cohort study included patients undergoing total mesorectal excision for nonmetastatic rectal cancer after SC-TNT or CRT between 2010 and 2018. Univariate analysis of severe POM and multiple secondary outcomes, including overall POM, intraoperative complications, and resection margins, was performed. Logistic regression of severe POM was also performed. Results: Of 415 included patients, 156 (38%) received SC-TNT and 259 (62%) received CRT. The cohorts were largely similar, though patients with higher tumors (69.9% vs 47.5%, P 〈 0.0001) or node-positive disease (76.9% vs 62.6%, P = 0.004) were more likely to receive SC-TNT. We found no difference in incidence of severe POM (9.6% SC-TNT vs 12.0% CRT, P = 0.46) or overall POM (39.7% SC-TNT vs 37.5% CRT, P = 0.64) between cohorts. Neoadjuvant regimen was also not associated with a difference in severe POM (odds ratio 0.42, 95% confidence interval 0.04–4.70, P = 0.48) in multivariate analysis. There was no significant association between neoadjuvant regimen and any secondary outcome. Conclusion: In rectal cancer patients treated with SC-TNT and proctectomy, we found no significant association with POM compared to patients undergoing CRT. SC-TNT does not significantly increase the risk of POM compared to CRT.
    Type of Medium: Online Resource
    ISSN: 0003-4932 , 1528-1140
    RVK:
    Language: English
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date: 2022
    detail.hit.zdb_id: 2641023-0
    detail.hit.zdb_id: 2002200-1
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 6
    Online Resource
    Online Resource
    Akshantala Enterprises Private Limited ; 2021
    In:  Journal of Evolution of Medical and Dental Sciences Vol. 10, No. 34 ( 2021-8-23), p. 2934-2938
    In: Journal of Evolution of Medical and Dental Sciences, Akshantala Enterprises Private Limited, Vol. 10, No. 34 ( 2021-8-23), p. 2934-2938
    Abstract: BACKGROUND The occurrence of QT interval prolongation is higher in subjects with type 2 diabetes mellitus (T2DM). Duration of QT interval corrected (QTc) for heart rate is independently related with severity of cardiovascular diseases in diabetics. This study was proposed to assess the QTc prolongation as a diagnostic tool for cardiovascular disease in T2DM patients. METHODS This study included 100 diabetic patients admitted in wards of a tertiary care center. A thorough clinical examination was carried out for all the patients. Patients were investigated for the fasting blood glucose level, glycated haemoglobin (HbA1c), lipid profile & electrocardiogram (ECG). Data was represented as percentage. Mean and standard deviation (SD) of quantitative variables were tabulated, t test was used for correlation and receiver operating characteristic (ROC) curve was used for evaluating area under curve. P 〈 0.05 was considered statistically significant. RESULTS Male preponderance was observed. All the study subjects had a prolonged period of diabetes with various metabolic complications. The area under the curve estimation of QTc 〉 400 ms with respect to HbA1c and duration of diabetes showed significant correlation between longer duration of diabetes and raised HbA1c associated with raised QTc interval (P 〈 0.05). CONCLUSIONS Diagnosis of prolonged QTc interval could be utilized for estimating cardiovascular risk in diabetes patients. It can be easily assessed on ECG besides being a noninvasive investigation which is also affordable in evaluating the cardiovascular risk in T2DM patients. KEY WORDS Blood Glucose, Cardiovascular Diseases, Electrocardiography, Glycated Haemoglobin A, Long QT Syndrome, Type 2 Diabetes Mellitus
    Type of Medium: Online Resource
    ISSN: 2278-4748 , 2278-4802
    Uniform Title: English
    Language: Unknown
    Publisher: Akshantala Enterprises Private Limited
    Publication Date: 2021
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 7
    In: Journal of Evolution of Medical and Dental Sciences, Akshantala Enterprises Private Limited, Vol. 10, No. 37 ( 2021-9-13), p. 3242-3246
    Abstract: BACKGROUND Type 2 diabetes mellitus (T2DM) has emerged as the leading comorbidity in patients with coronavirus disease 2019 (COVID-19). However, data obtained on the correlation between the incidences of T2DM with COVID-19 are limited. We wanted to assess the severity of patients with T2DM and COVID-19, and study the correlation between the high-resolution computed tomography (HRCT) findings and hyperglycaemia with disease severity. METHODS This cross-sectional study included 100 patients with a history of diabetes and diagnosed COVID-19 positive. Data were collected using a semi-structured questionnaire. P 〈 0.05 was considered statistically significant. RESULTS The mean age was 58.81 ± 11.43 years with male preponderance (71 %). The difference was statistically significant in mean glycated haemoglobin (HbA1c) (7.32 ± 1.39 %, P 〈 0.001), mean high - density lipoprotein (HDL ; 39.78 ± 6.76 mmol / L), low - density lipoprotein (LDL; 63.23 ± 13.36 mmol / L), and triglyceride (TG; 140.70 ± 43.57 mg / dL) levels (P 〈 0.05) in different CT severity score. Mean HbA1c (P 〈 0.001), LDL, and CT severity scores (P = 0.034 and P 〈 0.001) were highly significant in patients who died than the discharged patients. A significant positive correlation was seen between CT severity score with HbA1c, LDL, and TG levels and chances of death (P 〈 0.001) rates, and also between the patients who died and HbA1c (P 〈 0.001) and LDL (P = 0.034) levels and CT severity score (P 〈 0.001). CONCLUSIONS Ideal management of the metabolic equilibrium of glucose was crucial in assuring an improved clinical outcome. Increased surveillance was warranted for diabetic COVID-19 patients. KEY WORDS COVID-19, Glycated Haemoglobin A, Hyperglycaemia, Severe Acute Respiratory Syndrome Coronavirus 2
    Type of Medium: Online Resource
    ISSN: 2278-4748 , 2278-4802
    Uniform Title: English
    Language: Unknown
    Publisher: Akshantala Enterprises Private Limited
    Publication Date: 2021
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 8
    Online Resource
    Online Resource
    Ovid Technologies (Wolters Kluwer Health) ; 2018
    In:  Diseases of the Colon & Rectum Vol. 61, No. 12 ( 2018-12), p. 1403-1409
    In: Diseases of the Colon & Rectum, Ovid Technologies (Wolters Kluwer Health), Vol. 61, No. 12 ( 2018-12), p. 1403-1409
    Abstract: Thoracic epidural analgesia has been shown to be an effective method of pain control. The utility of epidural analgesia as part of an enhanced recovery after surgery protocol is debatable. OBJECTIVE: This study aimed to determine if the use of thoracic epidural analgesia in an enhanced recovery after surgery protocol decreases hospital length of stay or inpatient opioid consumption after elective colorectal resection. DESIGN: This is a single-institution retrospective cohort study. SETTINGS: The study was performed at a high-volume, tertiary care center in the Midwest. An institutional database was used to identify patients. PATIENTS: All patients undergoing elective transabdominal colon or rectal resection by board-certified colon and rectal surgeons from 2013 to 2017 were included. MAIN OUTCOME MEASURES: The main outcome was length of stay. The secondary outcome was oral morphine milligram equivalents consumed during the first 48 hours. RESULTS: There were 1006 patients (n = 815 epidural, 191 no epidural) included. All patients received multimodal analgesia with opioid-sparing agents. Univariate analysis demonstrated no difference in length of stay between those who received thoracic epidural analgesia and those who did not (median, 4 vs 5 days; p = 0.16), which was substantiated by multivariable linear regression. Subgroup analysis showed that the addition of epidural analgesia resulted in no difference in length of stay regardless of an open (n = 362; p = 0.66) or minimally invasive (n = 644; p = 0.46) approach. Opioid consumption data were available after 2015 (n = 497 patients). Univariate analysis demonstrated no difference in morphine milligram equivalents consumed in the first 48 hours between patients who received epidural analgesia and those who did not (median, 135 vs 110 oral morphine milligram equivalents; p = 0.35). This was also confirmed by multivariable linear regression. LIMITATIONS: The retrospective observational design was a limitation of this study. CONCLUSION: The use of thoracic epidural analgesia within an enhanced recovery after surgery protocol was not found to be associated with a reduction in length of stay or morphine milligram equivalents consumed within the first 48 hours. We cannot recommend routine use of thoracic epidural analgesia within enhanced recovery after surgery protocols. See Video Abstract at http://links.lww.com/DCR/A765.
    Type of Medium: Online Resource
    ISSN: 0012-3706
    Language: English
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date: 2018
    detail.hit.zdb_id: 2046914-7
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 9
    In: American Journal of Nephrology, S. Karger AG, Vol. 40, No. 6 ( 2014), p. 535-545
    Abstract: 〈 b 〉 〈 i 〉 Background/Aims: 〈 /i 〉 〈 /b 〉 Vitamin D insufficiency drives secondary hyperparathyroidism (SHPT) and is associated with increased cardiovascular mortality in patients with chronic kidney disease (CKD). SHPT is poorly addressed by current vitamin D repletion options. The present study evaluated a novel investigational vitamin D repletion therapy: a modified-release (MR) formulation of calcifediol designed to raise serum 25-hydroxyvitamin D in a gradual manner to minimize the induction of CYP24 and, thereby, improve the SHPT control. 〈 b 〉 〈 i 〉 Methods: 〈 /i 〉 〈 /b 〉 This randomized, double-blind, placebo-controlled trial evaluated MR calcifediol in CKD subjects (n = 78) with plasma intact parathyroid hormone (iPTH) 〉 70 pg/ml and serum total 25-hydroxyvitamin D 〈 30 ng/ml. Subjects received daily treatment for six weeks with oral MR calcifediol (30, 60 or 90 µg) or a placebo. 〈 b 〉 〈 i 〉 Results: 〈 /i 〉 〈 /b 〉 More than 90% of subjects treated with MR calcifediol achieved serum 25-hydroxyvitamin D levels ≥30 ng/ml versus 3% of subjects treated with placebo (p 〈 0.0001). Mean plasma iPTH decreased from baseline (140.3 pg/ml) by 20.9 ± 6.2% (SE), 32.8 ± 5.7 and 39.3 ± 4.3% in the 30, 60 and 90 µg dose groups, respectively, and increased 17.2 ± 7.8% in the pooled placebo group (p 〈 0.005). No clinically significant safety concerns arose during MR calcifediol treatment. 〈 b 〉 〈 i 〉 Conclusion: 〈 /i 〉 〈 /b 〉 Oral MR calcifediol appears safe and highly effective in treating SHPT associated with vitamin D insufficiency in CKD.
    Type of Medium: Online Resource
    ISSN: 0250-8095 , 1421-9670
    Language: English
    Publisher: S. Karger AG
    Publication Date: 2014
    detail.hit.zdb_id: 1468523-1
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...